New imaging showdown: can PSMA PET and MRI-RSI outperform standard MRI for prostate cancer?
NCT ID NCT07568613
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study compares two advanced imaging techniques—PSMA PET/CT and MRI-RSI—against the current standard MRI for finding and outlining prostate tumors in 50 men with newly diagnosed, intermediate- to high-risk prostate cancer. The goal is to see if these newer methods improve tumor detection and reduce variability in treatment planning. Participants will undergo all imaging tests, and results will be compared to biopsy findings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
German Oncology Center
RECRUITINGLimassol, 4108, Cyprus
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.